Saturday, October 18, 2025
HomeTagsHealthcare

Healthcare

Central Colorado Dermatology Joins Epiphany Dermatology

Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced it has expanded its presence in the Rocky Mountain...

Paine Schwartz Completes Strategic Investment in Hendrix Genetics, a Leading Multi-Species Animal Genetics and Technology Company

Hendrix Genetics (the "Company"), a leading multi-species animal genetics and technology company and Paine Schwartz Partners, a global leader in sustainable food chain investing,...

Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to a Find Tailored Treatment for the Complex Rare Disease

Scenic Biotech BV ('Scenic' or 'the Company'), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for...

Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial

Cellphire Therapeutics, Inc., a biotechnology company developing next-generation pooled allogeneic cellular therapeutics for application across multiple medical indications, announced that the 1st patient has...

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, announced the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics